Revenue market share of cold and flu drugs sold in Spain by company 2017-2018

Published by
J. Mendoza,
Jul 2, 2021
This statistic displays the market share of anti-flu and anti-cold drugs sold in Spain between October 2017 and September 2018, based on revenue and by pharmaceutical company. Over the period of time under consideration, Johnson & Johnson was the leading provider of these pharmaceutical products in Spain in terms of revenue, accounting for over 30 percent of total sales within this segment.

Revenue market share of anti-flu and anti-cold drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

December 2018

Region

Spain

Survey time period

October 2017 to September 2018

Open this statistic in...
Spanish
Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you

Global overview

3

U.S. overview

7

Disease burden

8

Vaccination coverage

8

Impact of vaccination

5

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

Influenza in the U.S.Geriatric health in the U.S.HealthChildren's health in the U.S.Diseases
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu